Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VIR | RAPP | VCEL | ||
| Company | Vir Biotechnology Inc | Rapport Therapeutics Inc | Vericel Corporation | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.85 | 37.38 | 33.92 | ||
| High | 10.96 | 37.94 | 34.39 | ||
| Low | 10.52 | 35.57 | 33.46 | ||
| Latest | 10.67 | 36.78 | 34.37 | ||
| Change | -0.16 | -0.17 | +0.70 | ||
| % Change | -1.48% | -0.46% | +2.08% | ||
| Volume | 2,405,700 | 338,300 | 457,600 | ||
| 20-Day Average Volume | 1,941,595 | 360,270 | 683,620 | ||
| Previous Close | 10.83 | 36.95 | 33.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.62 | 33.78 | 33.40 | ||
| 20-Day Raw Stochastic | 70.88% | 70.22% | 76.88% | ||
| 20-Day Relative Strength | 61.92 | 63.02 | 50.86 | ||
| Weighted Alpha | +99.77 | +112.77 | -13.40 | ||
| Today's Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Last Month's Opinion | 88% Buy | 24% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.01% since 04/15/26 | +0.19% since 04/15/26 | -2.83% since 04/15/26 | ||
| Low | 10.24 on 04/16/26 | 35.57 on 04/22/26 | 33.23 on 04/21/26 | ||
| High | 11.66 on 04/20/26 | 40.92 on 04/17/26 | 36.00 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +17.25% since 03/20/26 | +35.82% since 03/20/26 | +9.42% since 03/20/26 | ||
| Low | 8.26 on 03/30/26 | 26.96 on 03/23/26 | 28.95 on 03/27/26 | ||
| High | 11.66 on 04/20/26 | 40.92 on 04/17/26 | 36.00 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | +44.19% since 01/22/26 | +31.73% since 01/22/26 | -12.19% since 01/22/26 | ||
| Low | 6.86 on 02/05/26 | 25.21 on 02/05/26 | 28.95 on 03/27/26 | ||
| High | 11.66 on 04/20/26 | 40.92 on 04/17/26 | 39.48 on 01/23/26 | ||
| 6-Month | |||||
| %Chg | +74.35% since 10/22/25 | +47.71% since 10/22/25 | -5.65% since 10/22/25 | ||
| Low | 4.82 on 11/07/25 | 23.75 on 11/17/25 | 28.95 on 03/27/26 | ||
| High | 11.66 on 04/20/26 | 40.92 on 04/17/26 | 43.00 on 11/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,746,164 | 1,766,210 | 1,714,880 | ||
| Shares Outstanding, K | 161,234 | 47,800 | 50,932 | ||
| Annual Sales | 68,560,000 | 0 | 276,260,000 | ||
| Annual Net Income | -437,990,000 | -111,480,000 | 16,520,000 | ||
| Last Quarter Sales | 64,070,000 | 0 | 92,920,000 | ||
| Last Quarter Net Income | -42,920,000 | -33,760,000 | 23,240,000 | ||
| 60-Month Beta | 1.66 | 1.09 | 1.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 02/23/26 | -0.72 on 03/10/26 | 0.45 on 02/26/26 | ||
| Latest Earnings Date | 05/06/26 | 05/14/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 115.52 | ||